List of insiders holdings for Arbutus Biopharma Corp:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Gline Matthew Director 10% Owner | 2025-03-06 16:07:01 | 0 38,847,462 | 38,847,462 | Form 3 |
| Roivant Sciences Ltd. 10% Owner | 2025-02-25 07:19:33 | 38,847,462 0 | 38,847,462 | Form 13D |
| McElhaugh Michael J. Interim President & CEO | 2025-02-19 18:25:40 | 2,376,803 0 | 2,376,803 | Form 4 |
| Sofia Michael J. Chief Scientific Officer | 2024-02-05 19:54:25 | 1,922,921 167,162 | 2,090,083 | Form 4 |
| Collier William H. President and CEO | 2023-02-03 16:10:34 | 1,082,500 0 | 1,082,500 | Form 4 |
| Nguyen Tuan Chief Financial Officer | 2025-04-01 17:47:47 | 750,000 0 | 750,000 | Form 4/A |
| HASTINGS DAVID C Chief Financial Officer | 2025-02-19 18:25:30 | 615,624 0 | 615,624 | Form 4 |
| Howard Elizabeth EVP, GC, Compliance | 2023-02-03 16:10:11 | 364,724 0 | 364,724 | Form 4 |
| Naftzger J. Christopher General Counsel and CCO | 2025-02-19 18:25:53 | 360,844 0 | 360,844 | Form 4 |
| Murray Mark J. President and CEO | 2019-03-05 18:07:04 | 357,500 0 | 357,500 | Form 4 |
| Sims Karen Chief Medical Officer | 2025-02-19 18:25:20 | 355,794 0 | 355,794 | Form 4 |
| Androski Lindsay President and CEO | 2025-03-20 16:08:32 | 310,422 0 | 310,422 | Form 4 |
| Picchio Gaston Chief Development Officer | 2022-01-20 17:54:07 | 256,500 0 | 256,500 | Form 4 |
| Beardsley Robert A Director | 2025-03-20 16:10:16 | 157,600 0 | 157,600 | Form 4 |
| Hasija Anuj Director | 2025-03-20 16:14:12 | 157,600 0 | 157,600 | Form 4 |
| HENRIQUES RICHARD C JR Director | 2024-05-24 16:14:32 | 67,000 0 | 67,000 | Form 4 |
| Meyers James R Director | 2024-05-24 16:12:52 | 67,000 0 | 67,000 | Form 4 |
| Rewolinski Melissa Director | 2024-05-24 16:10:50 | 67,000 0 | 67,000 | Form 4 |
| BURGESS DANIEL D Director | 2024-05-24 16:17:52 | 67,000 0 | 67,000 | Form 4 |
| Torti Frank Director | 2024-05-24 16:07:10 | 67,000 0 | 67,000 | Form 4 |
| MANCHESTER KEITH S Director | 2024-08-16 16:07:41 | 46,069 0 | 46,069 | Form 4 |
| Tran Tram Director | 2022-05-26 16:13:28 | 41,000 0 | 41,000 | Form 4 |
| Symonds William T. Chief Development Officer | 2018-04-17 20:17:14 | 30,000 0 | 30,000 | Form 4 |
| POTTER MYRTLE S Director | 2019-08-20 16:17:44 | 22,000 0 | 22,000 | Form 4 |
| Cheng Andrew Director | 2021-06-07 16:24:23 | 22,000 0 | 22,000 | Form 4 |
| CONRAD HERBERT J Director | 2018-06-22 19:30:17 | 22,000 0 | 22,000 | Form 4 |
| Ramaswamy Vivek Director | 2018-06-22 16:24:00 | 22,000 0 | 22,000 | Form 4 |
| KARBE FRANK Director | 2017-06-23 16:01:20 | 22,000 0 | 22,000 | Form 4 |
| VandenEnden Koert Chief Accounting Officer | 2018-12-13 15:11:12 | 7,500 0 | 7,500 | Form 4 |
| Lutwyche Peter Former Chief Tech. Officer | 2018-04-13 17:28:01 | 0 0 | 0 | Form 4 |
| Gardiner Diane Former VP, Human Resources | 2015-03-18 18:49:01 | 0 0 | 0 | Form 4 |
| Brennan Paul A. Sr VP, Business Development | 2015-03-18 18:54:41 | 0 0 | 0 | Form 4 |
| Jewell Donald Gordon Former Director Director | 2015-03-18 19:04:57 | 0 0 | 0 | Form 4 |
| Phillips Peggy V Former Director Director | 2015-03-18 19:09:35 | 0 0 | 0 | Form 4 |
| Bishop Joseph E Director | 2025-03-06 16:11:44 | 0 0 | 0 | Form 3 |
| Higgins Patrick T. Chief Business Officer | 2016-05-02 12:59:14 | 0 0 | 0 | Form 4 |
| VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Sundheim Daniel S. 10% Owner | 2019-07-12 16:57:23 | 0 0 | 0 | Form 13D |
| Abrams Michael J. Managing Director Director | 2016-10-06 13:45:40 | 0 0 | 0 | Form 4 |
| Kowalski Mark Sr VP & Chief Medical Officer | 2016-10-06 13:47:09 | 0 0 | 0 | Form 4 |
| Cousins Bruce Exec VO & CFO | 2018-02-21 14:04:09 | 0 0 | 0 | Form 4 |
| Venker Eric Director | 2020-02-19 08:01:49 | 0 0 | 0 | Form 3 |
| SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF Holdings (UK) LLP SVF GP (Jersey) Ltd Former 10% Owner | 2019-07-12 19:46:18 | 0 0 | 0 | Form 4 |
| QVT Associates GP LLC QVT Fund V LP See Remarks 10% Owner | 2019-07-12 16:39:53 | 0 0 | 0 | Form 4 |
| VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon Former 10% Owner | 2019-07-12 20:38:58 | 0 0 | 0 | Form 4 |
| VIKING GLOBAL PERFORMANCE LLC Viking Global Equities LP Viking Global Equities II LP VGE III Portfolio Ltd. Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon Former 10% Owner | 2019-07-12 20:40:21 | 0 0 | 0 | Form 4 |
| Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan See remarks | 2019-07-12 16:51:48 | 0 0 | 0 | Form 4 |
| Machado Patrick Former 10% Owner | 2019-07-16 17:31:32 | 0 0 | 0 | Form 13D |
| Lo Andrew Former 10% Owner | 2019-07-16 17:43:02 | 0 0 | 0 | Form 13D |
| KISNER DANIEL L Former Director Director | 2015-03-16 17:46:20 | 0 0 | 0 | Form 4 |